2012
DOI: 10.3390/molecules171113530
|View full text |Cite
|
Sign up to set email alerts
|

Synthesis and Modifications of Phosphinic Dipeptide Analogues

Abstract: Pseudopeptides containing the phosphinate moiety (-P(O)(OH)CH2-) have been studied extensively, mainly as transition state analogue inhibitors of metalloproteases. The key synthetic aspect of their chemistry is construction of phosphinic dipeptide derivatives bearing appropriate side-chain substituents. Typically, this synthesis involves a multistep preparation of two individual building blocks, which are combined in the final step. As this methodology does not allow simple variation of the side-chain structur… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2

Citation Types

0
36
0

Year Published

2013
2013
2019
2019

Publication Types

Select...
6
1

Relationship

0
7

Authors

Journals

citations
Cited by 55 publications
(36 citation statements)
references
References 128 publications
(197 reference statements)
0
36
0
Order By: Relevance
“…The use of phosphonates and phosphinates as inhibitors of C:N ligases by mimicking the transition state of the product of these enzymes at the active site has been reported . For example, compound 156 is a noncompetitive inhibitor of glutathionylspermidine synthase (GspS) from Crithidia fasciculata .…”
Section: Phosphorus‐containing Drugs As Transition‐state Inhibitorsmentioning
confidence: 99%
See 1 more Smart Citation
“…The use of phosphonates and phosphinates as inhibitors of C:N ligases by mimicking the transition state of the product of these enzymes at the active site has been reported . For example, compound 156 is a noncompetitive inhibitor of glutathionylspermidine synthase (GspS) from Crithidia fasciculata .…”
Section: Phosphorus‐containing Drugs As Transition‐state Inhibitorsmentioning
confidence: 99%
“…The use of phosphonates and phosphinates as inhibitors of C:Nl igasesb ym imicking the transition state of the product of these enzymes at the active site has been reported. [134][135][136] For example, compound 156 is an oncompetitive inhibitor of glutathionylspermidine synthase (GspS) [137] from Crithidia fasciculata. More excitingly,acompound structurally related to 156 coupled with spermidine gave rise to slow,t ight-binding inhibitors of GspS from Escherichia coli.…”
Section: Phosphorus-containing Drugs As Transitionstate Inhibitorsmentioning
confidence: 99%
“…Recently, several procedures have been reported for the synthesis of α-aminophosphonates under solvent and catalyst free conditions with excellent yield, or using easily available catalysts; moreover, these procedures seems to be extremely simple [27][28][29][30][31][32][33]. In continuation with our investigation on the synthesis of α-aminophosphonates [34][35][36][37][38][39][40][41][42], herein we report a green and mild protocol for the synthesis of α-aminophosphonates in aqueous media without a catalyst (Scheme 1).…”
mentioning
confidence: 99%
“…A number of excellent reviews on various aspects of their activity in natural systems have been published [16,17]. In view of the broad biological applications of the optically active α-amino-C-phosphinic acids and their peptidic derivatives, in the last years the development of suitable synthetic methodologies for their preparation in optically pure form has been a topic of great interest in several research groups [31,32]. In this context, now we would like to report herein a summary of the stereoselective synthesis of α-amino-C-phosphinic acids and their derivatives covering the last 20 years.…”
Section: Introductionmentioning
confidence: 99%